AC Immune S.A.ACIUNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank45
5Y CAGR-40.9%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-40.9%/yr
Long-term compound
Percentile
P45
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 8.11% |
| 2023 | 10.37% |
| 2022 | -11.92% |
| 2021 | -41.38% |
| 2020 | 15.56% |
| 2019 | 112.30% |
| 2018 | 20.56% |
| 2017 | 32.70% |
| 2016 | 131.76% |
| 2015 | 2.05% |